Opioid Rx Down, but Overdoses and Deaths Up, AMA Report Shows

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 15, 2023.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Nov. 15, 2023 -- Opioid prescribing by physicians and other health professionals has decreased for the 13th consecutive year, down nearly 50 percent since 2012, while overdoses and deaths related to illicitly manufactured fentanyl, xylazine, and other synthetic substances continue to increase, according to the Overdose Epidemic Report 2023, released by the American Medical Association (AMA).

In 2022, more than 107,000 people died from a drug-related overdose in the United States, with the epidemic increasingly impacting young people, Black and Brown people, and pregnant people. Since 2018, naloxone dispensing has increased more than 200 percent, and buprenorphine dispensed by community pharmacies for the treatment of opioid use disorder (OUD) nearly doubled in the past 10 years.

The AMA calls for action on eight strategies to remove barriers and increase patients' access to evidence-based care for OUD, including take-home medications, telehealth options, and care for justice-involved persons. Additionally, the AMA calls for making nonopioid pain care alternatives more accessible and affordable and meeting social determinants of health needs. Other recommendations include the enforcement of mental health parity laws and increasing harm reduction resources such as naloxone, syringe services programs, and fentanyl test strips.

"Naloxone is one success story we've seen this year because access to opioid-overdose reversal medications continues to save tens of thousands of lives," Bobby Mukkamala, M.D., chair of the AMA Substance Use and Pain Care Task Force, said in a statement. "Unfortunately, we are at a place where naloxone needs to be available as easily as a first aid kit or a defibrillator in public spaces."

AMA Overdose Epidemic Report 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-16 08:22

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords